NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email JPMorgan Chase CEO Jamie Dimon said on Monday that the rising U.S. national debt is going to create a “tough time” for the bond market and could eventually cause spreads to widen, he told Fox Business’ “Mornings with Maria” program.Read More